Last reviewed · How we verify

NCT04819646

Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort

Completed NA Last updated 13 January 2023
What this trial tests

NA trial testing Marine Lipid Oil Concentrate Formulation in Inflammation in 31 participants. Completed in 2 November 2021.

Timeline
7 January 2021
Primary endpoint
3 September 2021
2 November 2021

Quick facts

Lead sponsorSupplement Formulators, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment31
Start date7 January 2021
Primary completion3 September 2021
Estimated completion2 November 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Supplement Formulators, Inc.

Who can join

Adults 35 to 75, any sex, with Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to assess the efficacy and safety of a Marine Lipid Oil Concentrate formulation on inflammation/discomfort and overall well-being in male and female subjects who are generally healthy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inflammation

Currently open trials in the same condition.

Other Supplement Formulators, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04819646.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing